Cognitive & Neuroprotection
Cortexin
Last updated
Dosing on file unverified
10-20 mg/day IM for 10 days; Stroke: 10 mg 2-3x/day; Chronic ischemia: 10-20 mg/day for 10 days, repeated after 6 months
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 3
-
human RCT
[Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic strokes] (Zh Nevrol Psikhiatr Im S S Korsakova 2025) graded on: names a randomised controlled trial — the indexed publication type — “Randomized Controlled”
-
animal in vivo
Cortexin modulates OPG/RANK/RANKL and TRPC1 expression in cerebral ischemia-reperfusion injury. graded on: an animal model — read from the indexed abstract — “Rats”
-
animal in vivo
Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay. graded on: an animal model — read from the indexed abstract — “rat”
Notes unverified prose
Approved in Russia; dose-dependent RCT: 10 mg vs 20 mg IM for 10 days; low-dose stroke study: 10 mg 3x/day IM; DIACORT multicenter RCT; PMID: 41524350
Not on file 8
8 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- molecular weightnothing we hold supplies it
- molecular formulanothing we hold supplies it
- CAS registry numbernothing we hold supplies it
- PubChem identifiernothing we hold supplies it
- amino-acid sequencenot applicable to this compound
- SMILES stringnothing we hold supplies it
- InChInothing we hold supplies it
- InChI keynothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.